Wellmass Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 10 Months 13 Days
- Last Filing with ROC 31 Mar 2024
About Wellmass Pharma
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sukhdev Gehlot and Manju Gehlot serve as directors at the Company.
- CIN/LLPIN
U21003KA2024PTC184443
- Company No.
184443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2024
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wellmass Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhdev Gehlot  | Director | 07-Feb-2024 | Current |
| Manju Gehlot | Director | 07-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Wellmass Pharma.
Enhance accessibility to Wellmass Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Wellmass Pharma?
Unlock access to Wellmass Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Velnik Infraheights Private LimitedActive 4 years 24 days
Sukhdev Gehlot and Manju Gehlot are mutual person
- Smkdr Hotels And Resorts Private LimitedActive 4 years 3 months
Sukhdev Gehlot and Manju Gehlot are mutual person
- Velnik India Marketing Private LimitedActive 6 years 7 months
Sukhdev Gehlot and Manju Gehlot are mutual person
- Velnik India Welfare FoundationActive 1 year 2 months
Sukhdev Gehlot and Manju Gehlot are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellmass Pharma?
Wellmass Pharma has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellmass Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellmass Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
